IOVANCE BIOTHERAPEUTICS, INC. Trading Securities, Unrealized Holding Loss
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Trading Securities, Unrealized Holding Loss of $1.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:TradingSecuritiesUnrealizedHoldingLoss · last filed 2018-03-12
- IOVANCE BIOTHERAPEUTICS, INC. trading securities, unrealized holding loss for the quarter ending 2017-06-30 was -$14.00K.
- IOVANCE BIOTHERAPEUTICS, INC. trading securities, unrealized holding loss for the quarter ending 2017-03-31 was $15.00K.
- IOVANCE BIOTHERAPEUTICS, INC. trading securities, unrealized holding loss for the quarter ending 2016-12-31 was $46.00K.
- IOVANCE BIOTHERAPEUTICS, INC. trading securities, unrealized holding loss for the quarter ending 2016-09-30 was -$14.00K.
- IOVANCE BIOTHERAPEUTICS, INC. trading securities, unrealized holding loss for fiscal 2016 was $32.00K.
- IOVANCE BIOTHERAPEUTICS, INC. trading securities, unrealized holding loss for fiscal 2015 was $0.00.
| Period end | Trading Securities, Unrealized Holding Loss 3 month | Trading Securities, Unrealized Holding Loss 6 month | Trading Securities, Unrealized Holding Loss 9 month | Trading Securities, Unrealized Holding Loss 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $1.00K 10-Q · filed 2017-08-03 | $47.00K derived: sum of 3 quarters · filed 2018-03-12 | $33.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2017-03-31 | $15.00K 10-Q · filed 2017-05-03 | $61.00K derived: sum of 2 quarters · filed 2018-03-12 | $47.00K derived: sum of 3 quarters · filed 2018-03-12 | $47.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $32.00K derived: sum of 2 quarters · filed 2018-03-12 | $32.00K derived: sum of 3 quarters · filed 2018-03-12 | $32.00K 10-K · filed 2018-03-12 |
| 2016-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$14.00K derived: sum of 2 quarters · filed 2016-11-04 | -$14.00K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |